share_log
Reuters ·  Nov 25 20:02
BioLine RX Ltd: To Evaluate Additional Asset Opportunities in 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment